Acrivon Therapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold ACRV, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
10
Funds holding
$617370
Total value held
Selling
4 added/new · 5 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $290425 | 208939 | +3815 | +1.86% |
| 2 | State Street Corp | $93332 | 67145 | — | Held |
| 3 | Northern Trust Corp | $67973 | 48902 | -14816 | -23.25% |
| 4 | Morgan Stanley | $50973 | 36671 | -10160 | -21.70% |
| 5 | Citigroup Inc | $35167 | 14592 | -1713 | -10.51% |
| 6 | Marex Group Plc | $27800 | 20000 | +5920 | +42.05% |
| 7 | Bank Of America Corp /De/ | $22953 | 16513 | -934 | -5.35% |
| 8 | Goldman Sachs Group Inc | $20491 | 14742 | -104680 | -87.66% |
| 9 | Barclays Plc | $8256 | 5940 | — | NEW BUY |
| 10 | Royal Bank Of Canada | $0 | 25 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.